Smoking increases oral HPV persistence among men: 7-year follow-up study

被引:55
|
作者
Kero, K. [1 ]
Rautava, J. [2 ,3 ,4 ]
Syrjanen, K. [5 ,6 ]
Willberg, J. [2 ,3 ,4 ]
Grenman, S. [1 ]
Syrjanen, S. [2 ,3 ,4 ]
机构
[1] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynecol, Turku 20521, Finland
[2] Univ Turku, Fac Med, Med Res Lab, Inst Dent, Turku 20521, Finland
[3] Univ Turku, Inst Dent, Fac Med, Dept Oral Pathol, Turku 20521, Finland
[4] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland
[5] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[6] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil
关键词
FINNISH FAMILY HPV; HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; HIGH PREVALENCE; HEAD; MUCOSA; CARCINOMAS; SPOUSES; MOTHERS; ADULTS;
D O I
10.1007/s10096-013-1938-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Persistent high-risk human papillomavirus (HR-HPV) infection is the key event in the progression of HPV lesions, and more data are urgently needed on asymptomatic oral HPV infections in men. Asymptomatic fathers-to-be (n = 131, mean age 28.9 years) were enrolled in the cohort, sampled by serial oral scrapings at baseline and at 2-month, 6-month, 12-month, 24-month, 36-month, and 7-year follow-up visits to accomplish persistent and cleared HPV infections. HPV genotyping was performed using nested PCR and MultimetrixA (R) assay. Covariates of persistent and cleared oral HPV infections were analysed using generalised estimating equation (GEE) and Poisson regression. Altogether, 17 HPV genotypes were detected in male oral mucosa point prevalence, varying from 15.1 % to 31.1 %. Genotype-specific HPV persistence was detected in 18/129 men the mean persistence time ranging from 6.0 to 30.7 months. History of genital warts decreased (p = 0.0001; OR = 0.41, 95 % CI 0.33-0.51) and smoking increased (p = 0.033, OR = 1.92, 95 % CI 1.05-3.50) the risk of persistent species 7/9 HPV infections. Of the 74 HPV-positive men, 71.6 % cleared their infection actuarial and crude clearance times, varying between 1.4 and 79.6 months. No independent predictors were identified for species 7/9 clearance. At the last follow-up-visit, 50.1 % of the fathers had oral mucosal changes, correlating only with smoking (p = 0.046). To conclude, most of the persisting oral infections in males were caused by HPV16. Smoking increased while previous genital warts decreased oral HR-HPV persistence. No predictors of HR-HPV clearance were disclosed.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 50 条
  • [21] 7-YEAR FOLLOW-UP STUDY ON CARCINOMA OF STOMACH DIAGNOSED BY ENDOSCOPY
    GIBB, SP
    SAXENA, R
    CADY, B
    [J]. GASTROINTESTINAL ENDOSCOPY, 1975, 21 (04) : 188 - 188
  • [22] OUTCOME OF ACETABULAR FRACTURES - A 7-YEAR FOLLOW-UP
    YLINEN, P
    SANTAVIRTA, S
    SLATIS, P
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1989, 29 (01): : 19 - 24
  • [23] Neonatal intracranial hemangiopericytoma: a 7-year follow-up
    Yosef Laviv
    Shalom Michowitz
    Michael Schwartz
    [J]. Acta Neurochirurgica, 2012, 154 : 637 - 638
  • [24] Neonatal intracranial hemangiopericytoma: a 7-year follow-up
    Laviv, Yosef
    Michowitz, Shalom
    Schwartz, Michael
    [J]. ACTA NEUROCHIRURGICA, 2012, 154 (04) : 637 - 638
  • [25] Patellofemoral Arthroplasty 7-year Mean Follow-Up
    Mont, Michael A.
    Johnson, Aaron J.
    Naziri, Qais
    Kolisek, Frank R.
    Leadbetter, Wayne B.
    [J]. JOURNAL OF ARTHROPLASTY, 2012, 27 (03): : 358 - 361
  • [26] CARDIAC VALVE REPLACEMENT A 7-YEAR FOLLOW-UP
    ASTON, SJ
    MULDER, DG
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1971, 61 (04): : 547 - &
  • [27] Momelotinib therapy for myelofibrosis: a 7-year follow-up
    Ayalew Tefferi
    Daniela Barraco
    Terra L. Lasho
    Sahrish Shah
    Kebede H. Begna
    Aref Al-Kali
    William J. Hogan
    Mark R. Litzow
    Curtis A. Hanson
    Rhett P. Ketterling
    Naseema Gangat
    Animesh Pardanani
    [J]. Blood Cancer Journal, 8
  • [28] Momelotinib therapy for myelofibrosis: a 7-year follow-up
    Tefferi, Ayalew
    Barraco, Daniela
    Lasho, Terra L.
    Shah, Sahrish
    Begna, Kebede H.
    Al-Kali, Aref
    Hogan, William J.
    Litzow, Mark R.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Gangat, Naseema
    Pardanani, Animesh
    [J]. BLOOD CANCER JOURNAL, 2018, 8
  • [29] Alendronate in the prevention of osteoporosis: 7-year follow-up
    Sambrook, PN
    Rodriguez, JP
    Wasnich, RD
    Luckey, MM
    Kaur, A
    Meng, L
    Lombardi, A
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (06) : 483 - 488
  • [30] Alendronate in the prevention of osteoporosis: 7-year follow-up
    P. N. Sambrook
    J. P. Rodriguez
    R. D. Wasnich
    M. M. Luckey
    A. Kaur
    L. Meng
    A. Lombardi
    [J]. Osteoporosis International, 2004, 15 : 483 - 488